[The results of using high-dose methotrexate in treating osteogenic sarcoma]. 1990

N I Perevodchikova, and L A Eremina, and L V Manziuk, and P A Siniukov, and A N Fedenko, and A S Singin, and L K Moldovanova

The interim results of the use of high-dose methotrexate with leucovorin rescue for the treatment of 26 patients with osteogenic sarcoma are discussed. Preoperative chemotherapy was followed by marked regression of primary tumor in one out of seven patients with localized disease. In that group, metastasis-free period lasted 2, 3, 10+, 12, 17+ and 24+ months. Response was observed in two out of 19 (10.6%) cases of metastases. Toxic side-effects were moderate and were mainly nausea (38.5% of patients), vomiting (26.9%), elevation of serum transaminase levels (38.5%) and fever (30.7% of cases).

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011300 Preoperative Care Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed) Care, Preoperative,Preoperative Procedure,Preoperative Procedures,Procedure, Preoperative,Procedures, Preoperative
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005266 Femoral Neoplasms New abnormal growth of tissue in the FEMUR. Femoral Neoplasm,Neoplasm, Femoral,Neoplasms, Femoral

Related Publications

N I Perevodchikova, and L A Eremina, and L V Manziuk, and P A Siniukov, and A N Fedenko, and A S Singin, and L K Moldovanova
April 1981, National Cancer Institute monograph,
N I Perevodchikova, and L A Eremina, and L V Manziuk, and P A Siniukov, and A N Fedenko, and A S Singin, and L K Moldovanova
January 1981, Cancer treatment reports,
N I Perevodchikova, and L A Eremina, and L V Manziuk, and P A Siniukov, and A N Fedenko, and A S Singin, and L K Moldovanova
January 1994, Cancer chemotherapy and pharmacology,
N I Perevodchikova, and L A Eremina, and L V Manziuk, and P A Siniukov, and A N Fedenko, and A S Singin, and L K Moldovanova
November 1976, The American journal of nursing,
N I Perevodchikova, and L A Eremina, and L V Manziuk, and P A Siniukov, and A N Fedenko, and A S Singin, and L K Moldovanova
February 1978, Cancer treatment reports,
N I Perevodchikova, and L A Eremina, and L V Manziuk, and P A Siniukov, and A N Fedenko, and A S Singin, and L K Moldovanova
October 1976, Clinical orthopaedics and related research,
N I Perevodchikova, and L A Eremina, and L V Manziuk, and P A Siniukov, and A N Fedenko, and A S Singin, and L K Moldovanova
May 1975, The New England journal of medicine,
N I Perevodchikova, and L A Eremina, and L V Manziuk, and P A Siniukov, and A N Fedenko, and A S Singin, and L K Moldovanova
December 1978, American journal of veterinary research,
N I Perevodchikova, and L A Eremina, and L V Manziuk, and P A Siniukov, and A N Fedenko, and A S Singin, and L K Moldovanova
July 1977, Cancer treatment reports,
N I Perevodchikova, and L A Eremina, and L V Manziuk, and P A Siniukov, and A N Fedenko, and A S Singin, and L K Moldovanova
February 1982, American journal of clinical oncology,
Copied contents to your clipboard!